4//SEC Filing
de los Pinos Elisabet 4
Accession 0000950170-25-013830
CIK 0001501796other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 5:52 PM ET
Size
8.7 KB
Accession
0000950170-25-013830
Insider Transaction Report
Form 4
de los Pinos Elisabet
DirectorSee Remarks
Transactions
- Award
Stock Option (Right to Buy)
2025-02-03+255,680→ 255,680 totalExercise: $7.68Exp: 2035-02-02→ Common Stock (255,680 underlying) - Award
Common Stock
2025-02-03+194,320→ 502,661 total
Holdings
- 127,763(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on February 15, 2026, subject to the Reporting Person's continued service as of each such vesting date.
- [F2]On November 7, 2023, the Reporting Person filed a Form 4 which incorrectly included an additional 3,649 shares in the amount of securities beneficially owned directly after the reported transaction and excluded 3,649 shares from the amount of securities beneficially owned indirectly after the reported transaction. The Reporting Person's holdings after the transactions reported on this Form 4 reflect this correction.
- [F3]The shares are held by the Elisabet de los Pinos Revocable Trust U/D/T dated April 8, 2016, of which the Reporting Person is a trustee.
- [F4]The shares underlying this option vest as follows: 25% of the shares vest on February 3, 2026 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.
Documents
Issuer
Aura Biosciences, Inc.
CIK 0001501796
Entity typeother
Related Parties
1- filerCIK 0001889633
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 5:52 PM ET
- Size
- 8.7 KB